Abstract:e14024 Background: Choroid Plexus Carcinoma (CPC), a subtype of choroid plexus tumors (CPT), is a rare central nervous system neoplasm mostly affecting the pediatric population. The epidemiology of CPC is poorly understood due to the rarity of the disease. By analyzing the National Cancer Database (NCDB), we describe the demographic and social factors that influence the risk and current treatment of the cancer. Methods: We conducted a retrospective cohort analysis utilizing the 2018 National Cancer Database (NCDB) and included patients with Choroid Plexus Carcinoma with a histology-confirmed WHO grade III tumor, between ages 0-99 years (N = 202). Analysis was completed for the frequency of cases, types of treatment received, and overall survival within the pediatric population (age < 18 years, N = 139) and the adult population. Demographic factors were analyzed using Pearson Chi-squared tests, and survival was estimated using Kaplan-Meier curves. Results: The majority of the cases analyzed were white (55.4%), male (54%), and pediatric patients (66.8%, mean age at diagnosis = 15.17 years) with an average Charlson-Deyo Score of 0.24. The mean age at diagnosis of the pediatric population was 2.34 years (min = less than 1 years old/diagnosed in utero, max = 16, std. deviation = 3.84) while the mean age at diagnosis of the adult population was 43.49 years (min = 18, max = 84, std. deviation = 18.23.) The most common primary site for CPC was malignant neoplasm of the cerebral ventricle (87.6%) followed by malignant neoplasm of the brain stem (5.9%). Surgical procedure of the primary site was performed in 92.6% of cases including local excision, subtotal resection, resection, radical resection, partial resection of a lobe of brain, lobectomy, and surgery NOS. Radiation was not used 71.3% of the time, but was more than three times as likely to be used in the adult population after surgery than in the pediatric population after surgery (44.4% vs 14.4%, p value < 0.001). Most patients received chemotherapy (53%) with the administration of chemotherapy higher in the cohort less than 18 years old (69.8% versus 15.9%, p value < 0.001). Multiagent chemotherapy was administered as the first course of therapy as the top chemotherapeutic choice (86%) especially among the pediatric population (88.6%) compared to the adult population (60%) Palliative care was not provided in any of the cases. There was no statistical significance difference between the general survival of CPC between the pediatric and adult population. Conclusions: Historically, CPC is known as a pediatric cancer, but this NCDB study suggests that the frequency of the adult population affected is not negligible (31.2%). There is a difference regarding the current treatment of CPC in the pediatric versus adult population. Further study is needed to determine the impact of treatment and the importance of socioeconomic factors on the survival of CPC.

Intracranial Choroid Plexus Carcinomas: Report of 11 Cases from a Single Institution.

Primary adult choroid plexus carcinomas: a single-center experience with a systematic review

Primary Intracranial Choriocarcinoma: A Report of 8 Cases with Review of Literature

Choroid plexus carcinoma: A case report

Clinical Features and Prognostic Risk Factors of Choroid Plexus Tumors in Children

Clinical Features, Diagnosis, and Treatment of Primary Intracranial Choriocarcinoma in Children

Primary choroid plexus papilloma of the sellar region

Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

The epidemiology and current treatment of pediatric choroid plexus carcinoma: An analysis of the national cancer database.

Choroid plexus carcinoma with leptomeningeal spread in an adult: a case report and review of the literature

RARE-27. Treatment and outcomes in atypical choroid plexus papilloma: a single institution experience

RARE-17. HIGH-THROUGHPUT SCREEN IDENTIFIES POTENTIAL CHEMOTHERAPIES FOR CHOROID PLEXUS CARCINOMA TREATMENT USING INTRAARTERIAL STRATEGY

Predictive Factors of Overall Survival in Primary Intracranial Pure Choriocarcinoma.

Choroid Plexus Carcinomas with TP53 Germline Mutations: Management and Outcome

Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis

Choroid plexus papilloma of the cerebellopontine angle

Prognostic Factors and Nomogram for Choroid Plexus Tumors: A Population-Based Retrospective Surveillance, Epidemiology, and End Results Database Analysis

Primary carcinoma of the choroid plexus in the lateral ventricle

Surgical resection and adjuvant chemotherapy of familial intracranial choriocarcinoma

Primary Squamous Cell Carcinomas Arising in Intracranial Epidermoid Cysts: A Series of Nine Cases and Systematic Review

Final results of the Choroid Plexus Tumor study CPT-SIOP-2000